Research
Reaching PTSD Care: What Telehealth Trials Can—and Cannot—Teach MDMA Research
October 30, 2026
Keeping PTSD Care Moving While MDMA Remains Investigational
October 30, 2026
Designing a Durability Test: Relapse, Follow-Up, and Intervening Care
October 30, 2026
Choosing a Comparator for MDMA Trials: Why No Control Is Perfect
October 30, 2026
When a Boundary Concern Is Reported: Accountability in MDMA Research
October 30, 2026
From Inquiry to Randomization: Reading a Trial Screening Flowchart
October 30, 2026
Who Gets Into the Evidence? Recruitment Barriers in MDMA PTSD Research
October 30, 2026
Beyond a Lower PTSD Score: What Functional Outcomes Actually Measure
October 30, 2026
Building Accountable MDMA Research: A Trauma-Care Safeguards Framework
October 30, 2026
How to Audit a PTSD Trial Claim: An MDMA Evidence Workbook
October 30, 2026
MDMA and Couples Therapy: What a Six-Couple Pilot Can Tell Us
October 29, 2026
MDMA for Social Anxiety in Autistic Adults: Revisiting the Small Pilot
October 29, 2026
Page 1 of 2Older →